Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- P.H.S.
Summary
This study aims to identify T-helper lymphocyte epitopes in the development of a vaccine against equine infectious anemia virus in horses, focusing on reactivity to two specific proteins, p26 and p15.
Study Overview
The research focuses on equine infectious anemia virus (EIAV), a lentivirus affecting horses. Specifically, the authors examined two proteins—p26 and p15—encoded by the EIAV gag gene, associated with T-helper lymphocytes response. These responses are vital for the development of antiviral humoral responses and cytotoxic T lymphocyte (CTL) expansion. Identification of relevant T-helper lymphocyte epitopes could represent a significant step in developing an effective subunit peptide vaccine for EIAV.
Procedure and Findings
- By using partially overlapping peptides, the authors identified multiple and potentially promiscuous epitopes within the p26 protein.
- One identified peptide reacted with the peripheral blood mononuclear cells (PBMC) of all five EIAV-infected horses used in the study, while three other peptides reacted with PBMC from four out of five horses.
- Four additional peptides, containing both CTL and T-helper lymphocyte epitopes, were also identified.
- Notably, multiple epitopes were recognized in an area corresponding to the major homology region of the human immunodeficiency virus (HIV) – a region with significant sequence similarities to other lentiviruses.
Study of p15 Proteins
- The study also examined PBMC reactivity to p15 proteins from EIAV carrier horses.
- Various p15 peptides were shown to be reactive, although not all infected horses had T-helper lymphocytes recognizing p15 epitopes.
Implications of the Study
- The identification of T-helper lymphocyte epitopes reactive with PBMC from different horses, some of which encoded both CTL and T-helper lymphocyte epitopes, could contribute significantly to the creation of synthetic peptide or recombinant vector vaccines for EIAV.
- This research provides a potential advance in understanding and combating EIAV, which could have broader applications for understanding similar viruses and the immune response they provoke.
Cite This Article
Publication
Researcher Affiliations
- Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164, USA.
MeSH Terms
- Amino Acid Sequence
- Animals
- Capsid / chemical synthesis
- Capsid / immunology
- Carrier State
- Cell Division
- Epitopes, T-Lymphocyte / immunology
- Gene Products, gag / chemical synthesis
- Gene Products, gag / immunology
- Horses
- Infectious Anemia Virus, Equine / immunology
- Leukocytes, Mononuclear / cytology
- Molecular Sequence Data
- Peptides / chemical synthesis
- Peptides / immunology
- Recombinant Fusion Proteins / immunology
- T-Lymphocytes, Helper-Inducer / immunology
- Viral Core Proteins / chemical synthesis
- Viral Core Proteins / immunology
- Viral Matrix Proteins / chemical synthesis
- Viral Matrix Proteins / immunology
Grant Funding
- AI01260 / NIAID NIH HHS
- AI24291 / NIAID NIH HHS
References
- An LL, Whitton JL. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.. J Virol 1997 Mar;71(3):2292-302.
- Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.. J Immunol 1995 Jan 1;154(1):399-412.
- Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.. J Virol 1994 Jul;68(7):4700-4.
- Berzofsky JA. Development of artificial vaccines against HIV using defined epitopes.. FASEB J 1991 Jul;5(10):2412-8.
- Blazevic V, Ranki A, Krohn KJ. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.. AIDS Res Hum Retroviruses 1995 Nov;11(11):1335-42.
- Chong YH, Payne SL, Issel CJ, Montelaro RC, Rushlow KE. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.. J Virol 1991 Feb;65(2):1007-12.
- Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.. Science 1995 Jan 27;267(5197):483-9.
- Desrosiers RC. HIV with multiple gene deletions as a live attenuated vaccine for AIDS.. AIDS Res Hum Retroviruses 1992 Mar;8(3):411-21.
- Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.. Nature 1993 Mar 25;362(6418):359-62.
- Franke ED, Corradin G, Hoffman SL. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.. J Immunol 1997 Oct 1;159(7):3424-33.
- Gerencer M, Valpotić I, Jukić B, Tomasković M, Basić I. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS.. Arch Virol 1989;104(3-4):249-57.
- Godfrey DI, Kennedy J, Gately MK, Hakimi J, Hubbard BR, Zlotnik A. IL-12 influences intrathymic T cell development.. J Immunol 1994 Mar 15;152(6):2729-35.
- Grund CH, Lechman ER, Issel CJ, Montelaro RC, Rushlow KE. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus.. J Gen Virol 1994 Mar;75 ( Pt 3):657-62.
- Henderson LE, Sowder RC, Smythers GW, Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.. J Virol 1987 Apr;61(4):1116-24.
- Issel CJ, Horohov DW, Lea DF, Adams WV Jr, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.. J Virol 1992 Jun;66(6):3398-408.
- Kumar A, Arora R, Kaur P, Chauhan VS, Sharma P. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.. J Immunol 1992 Mar 1;148(5):1499-505.
- Kydd J, Antczak DF, Allen WR, Barbis D, Butcher G, Davis W, Duffus WP, Edington N, Grünig G, Holmes MA. Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991.. Vet Immunol Immunopathol 1994 Jul;42(1):3-60.
- Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.. J Virol 1999 Apr;73(4):2762-9.
- Malmquist WA, Barnett D, Becvar CS. Production of equine infectious anemia antigen in a persistently infected cell line.. Arch Gesamte Virusforsch 1973;42(4):361-70.
- Mammano F, Ohagen A, Höglund S, Göttlinger HG. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.. J Virol 1994 Aug;68(8):4927-36.
- Matsuo K, Nishino Y, Kimura T, Yamaguchi R, Yamazaki A, Mikami T, Ikuta K. Highly conserved epitope domain in major core protein p24 is structurally similar among human, simian and feline immunodeficiency viruses.. J Gen Virol 1992 Sep;73 ( Pt 9):2445-50.
- Maury W. Monocyte maturation controls expression of equine infectious anemia virus.. J Virol 1994 Oct;68(10):6270-9.
- McGuire TC, Adams DS, Johnson GC, Klevjer-Anderson P, Barbee DD, Gorham JR. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats.. Am J Vet Res 1986 Mar;47(3):537-40.
- McGuire, T. C., T. Harkins, S. R. Leib, and T. F. McElwain. Unpublished data.
- McGuire TC, O'Rourke KI, Baszler TV, Leib SR, Brassfield AL, Davis WC. Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anaemia virus gag and 5' pol genes.. J Gen Virol 1994 Apr;75 ( Pt 4):895-900.
- McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.. J Virol 1994 Mar;68(3):1459-67.
- Meister GE, Roberts CG, Berzofsky JA, De Groot AS. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.. Vaccine 1995 Apr;13(6):581-91.
- Montelaro RC, Ball JM, Rushlow KE. Equine retroviruses. The Retroviridae New York, N.Y: Plenum Press; 1993. pp. 257–360.
- Montelaro RC, Grund C, Raabe M, Woodson B, Cook RF, Cook S, Issel CJ. Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines.. AIDS Res Hum Retroviruses 1996 Mar 20;12(5):413-5.
- Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.. J Gen Virol 1988 Jul;69 ( Pt 7):1711-7.
- Nakamura Y, Kameoka M, Tobiume M, Kaya M, Ohki K, Yamada T, Ikuta K. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein.. Vaccine 1997 Apr;15(5):489-96.
- Obeid OE, Partidos CD, Steward MW. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus.. J Gen Virol 1993 Dec;74 ( Pt 12):2549-57.
- Oldstone MB. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players.. Virology 1997 Aug 4;234(2):179-85.
- O'Rourke K, Perryman LE, McGuire TC. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus.. J Gen Virol 1988 Mar;69 ( Pt 3):667-74.
- Partidos CD, Vohra P, Steward MW. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.. Immunology 1996 Feb;87(2):179-85.
- Perryman LE, O'Rourke KI, Mason PH, McGuire TC. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.. Immunology 1990 Dec;71(4):592-4.
- Planz O, Ehl S, Furrer E, Horvath E, Bründler MA, Hengartner H, Zinkernagel RM. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.. Proc Natl Acad Sci U S A 1997 Jun 24;94(13):6874-9.
- Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.. Science 1997 Nov 21;278(5342):1447-50.
- Rudensky Y, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules.. Nature 1991 Oct 17;353(6345):622-7.
- Sauzet JP, Déprez B, Martinon F, Guillet JG, Gras-Masse H, Gomard E. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.. Vaccine 1995 Oct;13(14):1339-45.
- Shirai M, Chen M, Arichi T, Masaki T, Nishioka M, Newman M, Nakazawa T, Feinstone SM, Berzofsky JA. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.. J Infect Dis 1996 Jan;173(1):24-31.
- Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.. J Immunol 1994 Jan 15;152(2):549-56.
- Stephens RM, Casey JW, Rice NR. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.. Science 1986 Feb 7;231(4738):589-94.
- Stuhler G, Schlossman SF. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.. Proc Natl Acad Sci U S A 1997 Jan 21;94(2):622-7.
- Stuhler G, Walden P. Collaboration of helper and cytotoxic T lymphocytes.. Eur J Immunol 1993 Sep;23(9):2279-86.
- Takeda A, Tuazon CU, Ennis FA. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.. Science 1988 Oct 28;242(4878):580-3.
- Tumas DB, Brassfield AL, Travenor AS, Hines MT, Davis WC, McGuire TC. Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker.. Immunobiology 1994 Dec;192(1-2):48-64.
- Wang SZ, Rushlow KE, Issel CJ, Cook RF, Cook SJ, Raabe ML, Chong YH, Costa L, Montelaro RC. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.. Virology 1994 Feb 15;199(1):247-51.
- Zhang W, Lonning SM, McGuire TC. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.. J Virol 1998 Dec;72(12):9612-20.
Citations
This article has been cited 3 times.- Liu C, Cook SJ, Craigo JK, Cook FR, Issel CJ, Montelaro RC, Horohov DW. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.. Vet Immunol Immunopathol 2014 Oct 15;161(3-4):161-9.
- Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC. Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.. Vet Immunol Immunopathol 2007 Jul 15;118(1-2):121-8.
- Fraser DG, Oaks JL, Brown WC, McGuire TC. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.. Immunology 2002 Mar;105(3):295-305.